Clovis Oncology Correlations
| CLVSQDelisted Stock | 0.12 0.02 20.00% |
The correlation of Clovis Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clovis Oncology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clovis Oncology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Significant diversification
The correlation between Clovis Oncology and NYA is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Clovis Oncology and NYA in the same portfolio, assuming nothing else is changed.
Clovis |
The ability to find closely correlated positions to Clovis Oncology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clovis Oncology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clovis Oncology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clovis Oncology to buy it.
Moving together with Clovis Pink Sheet
Moving against Clovis Pink Sheet
| 0.85 | AXP | American Express Earnings Call Tomorrow | PairCorr |
| 0.77 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
| 0.75 | NONOF | Novo Nordisk AS | PairCorr |
| 0.54 | SGEN | Seagen Inc Earnings Call This Week | PairCorr |
| 0.53 | MRK | Merck Company Earnings Call This Week | PairCorr |
| 0.8 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
| 0.78 | PG | Procter Gamble Earnings Call Tomorrow | PairCorr |
| 0.71 | JPM | JPMorgan Chase Financial Report 12th of July 2024 | PairCorr |
| 0.68 | BAC | Bank of America Financial Report 16th of July 2024 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Clovis Pink Sheet performing well and Clovis Oncology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Clovis Oncology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NOW | 1.28 | (0.03) | (0.01) | 0.02 | 2.06 | 2.84 | 8.90 | |||
| ATSG | 2.17 | (0.49) | 0.00 | (0.18) | 0.00 | 4.13 | 9.10 | |||
| CALT | 2.30 | (0.45) | 0.00 | (0.37) | 0.00 | 5.03 | 15.96 | |||
| NOKFF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MTX | 1.06 | 0.03 | 0.03 | 0.07 | 1.27 | 2.51 | 6.49 | |||
| ADI | 1.30 | (0.05) | (0.02) | 0.01 | 1.66 | 2.45 | 7.59 | |||
| UAL | 1.98 | 0.26 | 0.15 | 0.19 | 1.65 | 4.99 | 8.90 | |||
| RYAAY | 1.14 | 0.12 | 0.09 | 0.14 | 1.19 | 2.64 | 8.57 |
Clovis Oncology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clovis Oncology pink sheet to make a market-neutral strategy. Peer analysis of Clovis Oncology could also be used in its relative valuation, which is a method of valuing Clovis Oncology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Still Interested in Clovis Oncology?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Clovis Pink Sheet
If you are still planning to invest in Clovis Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clovis Oncology's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |